Skip to main content
. 2022 Mar 1;36(3):283–300. doi: 10.1007/s40263-021-00895-w

Fig. 8.

Fig. 8

Proportion of CD19+ B cell depletion over time by patient weight quartile. Simulation is for subcutaneous route with prefilled syringe and using phase 3 dosage regimen (i.e., three loading 20-mg doses given weekly followed by monthly 20-mg doses)